How can we future-proof medicines regulation in the post-COVID world?
Health Conversation
English - March 09, 2021 11:03 - 15 minutes - 36.5 MB - ★★★★★ - 1 ratingMedicine Health & Fitness Alternative Health health covid-19 r&d patients vaccines pharmaceutical pharma pharmaceutical industry research & development patient safety Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Fighting the fakes - what's industry's role?
Next Episode: Is intellectual property a barrier to access?
Welcome to 19 Conversations. Today we're asking Nathalie Moll, Director General of EFPIA, "How can we future-proof medicines regulation in the post-COVID world?". Listen to hear the discussion on this challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information.